| Primary |
| Asthma |
53.2% |
| Product Used For Unknown Indication |
19.1% |
| Chronic Obstructive Pulmonary Disease |
7.0% |
| Bronchitis |
3.6% |
| Dyspnoea |
3.4% |
| Cough |
2.5% |
| Bronchiolitis |
2.3% |
| Hypertension |
0.9% |
| Oedema Peripheral |
0.9% |
| Asthma Exercise Induced |
0.8% |
| Bronchospasm |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Lung Cyst |
0.8% |
| Wheezing |
0.8% |
| Abdominal Pain |
0.6% |
| Bronchopulmonary Dysplasia |
0.6% |
| Hypocalcaemia |
0.6% |
| Inhalation Therapy |
0.6% |
| Respiratory Disorder |
0.6% |
| Abdominal Discomfort |
0.4% |
|
| Drug Ineffective |
50.8% |
| Dyspnoea |
10.6% |
| Throat Irritation |
4.3% |
| Drug Effect Decreased |
3.8% |
| Tremor |
3.4% |
| Cough |
3.1% |
| Breath Alcohol Test Positive |
2.9% |
| Wheezing |
2.9% |
| Asthma |
2.2% |
| Rash |
1.7% |
| Dizziness |
1.4% |
| Headache |
1.4% |
| Heart Rate Increased |
1.4% |
| Lactic Acidosis |
1.4% |
| Oropharyngeal Pain |
1.4% |
| Overdose |
1.4% |
| Oxygen Saturation Abnormal |
1.4% |
| Respiratory Disorder |
1.4% |
| Tachycardia |
1.4% |
| Urticaria |
1.4% |
|
| Secondary |
| Asthma |
31.8% |
| Product Used For Unknown Indication |
12.6% |
| Chronic Obstructive Pulmonary Disease |
8.0% |
| Diabetes Mellitus |
6.2% |
| Dyspnoea |
5.1% |
| Rhinitis Allergic |
4.8% |
| Alanine Aminotransferase Increased |
4.4% |
| Drug Use For Unknown Indication |
4.4% |
| Oedema |
3.9% |
| Oedema Peripheral |
3.0% |
| Cough |
2.5% |
| Hepatic Enzyme Increased |
2.5% |
| Rhinitis |
1.8% |
| Blood Cholesterol Increased |
1.5% |
| Fluid Retention |
1.5% |
| Myalgia |
1.5% |
| Respiratory Tract Infection Viral |
1.5% |
| Hypertension |
1.1% |
| Influenza |
1.0% |
| Liver Disorder |
1.0% |
|
| Hypokalaemia |
30.8% |
| Drug Ineffective |
12.1% |
| Oedema Peripheral |
9.9% |
| Asthma |
5.5% |
| Lactic Acidosis |
4.4% |
| Tachycardia |
4.4% |
| Wheezing |
4.4% |
| Palpitations |
3.3% |
| Rash |
3.3% |
| Accidental Exposure |
2.2% |
| Angina Unstable |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Congestive Cardiomyopathy |
2.2% |
| Cystitis Haemorrhagic |
2.2% |
| Dyspnoea |
2.2% |
| Gastroenteritis Rotavirus |
2.2% |
| Maternal Exposure During Pregnancy |
2.2% |
| Medication Error |
2.2% |
| Abdominal Pain |
1.1% |
| Adverse Drug Reaction |
1.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.4% |
| Asthma |
14.2% |
| Drug Use For Unknown Indication |
10.9% |
| Chronic Obstructive Pulmonary Disease |
9.2% |
| Hypertension |
5.2% |
| Pain |
4.7% |
| Contraception |
3.0% |
| Depression |
2.7% |
| Anxiety |
2.2% |
| Diabetes Mellitus |
2.0% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Multiple Myeloma |
1.5% |
| Acne |
1.5% |
| Prophylaxis |
1.5% |
| Osteoporosis |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Emphysema |
1.4% |
| Atrial Fibrillation |
1.3% |
| Dyspnoea |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
|
| Dyspnoea |
11.3% |
| Pneumonia |
6.7% |
| Pain |
6.6% |
| Drug Ineffective |
6.4% |
| Vomiting |
6.3% |
| Death |
6.0% |
| Pulmonary Embolism |
5.4% |
| Asthma |
5.2% |
| Nausea |
5.2% |
| Anxiety |
4.7% |
| Deep Vein Thrombosis |
4.1% |
| Cholecystitis Chronic |
4.0% |
| Depression |
4.0% |
| Weight Decreased |
4.0% |
| Wheezing |
4.0% |
| Injury |
3.5% |
| Cough |
3.4% |
| Cholelithiasis |
3.2% |
| Chest Pain |
3.1% |
| Gallbladder Disorder |
3.1% |
|
| Interacting |
| Acne |
33.3% |
| Asthma |
33.3% |
| Multiple Allergies |
33.3% |
|
| Blood Pressure Increased |
50.0% |
| Oedema Peripheral |
50.0% |
|
